Uruganda ruhendutse cyane Cabozantinib Malate CAS 1140909-48-3 kuri Anti-Tumor
Ibisobanuro bigufi:
Kanseri y'inkondo y'umura, izwi kandi nka kanseri y'inkondo y'umura, ni cyo kibyimba gikunze kugaragara mu bagore mu myororokere y'abagore.HPV nikintu cyingenzi gishobora gutera indwara.Kanseri y'inkondo y'umura irashobora kwirindwa binyuze mu gusuzuma no gukingira buri gihe.Kanseri y'inkondo y'umura ikize cyane kandi prognoz ni nziza.
Indashyikirwa iza ku mwanya wa 1;serivisi ni iyambere;ubucuruzi buciriritse ni ubufatanye "ni filozofiya yumuryango wacu uhora yubahirizwa kandi ugakurikiranwa nisosiyete yacu ku ruganda ruhendutse rwo mu rwego rwo hejuru Cabozantinib Malate CAS 1140909-48-3 kuri Anti-Tumor, Kubera imikorere yacu ikomeye, twahoraga hafi ya imbere ya tekinoroji isukuye ibicuruzwa bishya.Twabaye umufatanyabikorwa wangiza ibidukikije ushobora kwishingikiriza.Dufate uyumunsi amakuru yinyongera!
Indashyikirwa iza ku mwanya wa 1;serivisi ni iyambere;ubucuruzi buciriritse nubufatanye "ni filozofiya yumuryango wacu uhora yubahirizwa kandi ugakurikiranwa nisosiyete yacuUbushinwa Cabozantinib Malate CAS 1140909-48-3 na Cabozantinib Malate CAS 1140909-48-3 Utanga isoko, ubu dufite uburambe bwimyaka 8 yumusaruro nuburambe bwimyaka 5 mubucuruzi nabakiriya kwisi yose.abakiriya bacu bakwirakwijwe cyane muri Amerika ya ruguru, Afurika n'Uburayi bw'Uburasirazuba.turashobora gutanga ibicuruzwa byiza cyane hamwe nigiciro cyapiganwa cyane.
Epidemiologiya
OMS yashyize ahagaragara mu 2018 ko ku isi hose abantu bandura kanseri y'inkondo y'umura bagera kuri 13 kuri 100000 muri Wei, kandi impfu ni abantu 7 kuri 100000 bazize kanseri y'inkondo y'umura.Muri 2018, habaruwe abagera kuri 569000 bashya ba kanseri y'inkondo y'umura na 311000 bapfa, muri bo 84% bakaba barabaye mu bihugu by’ubucuruzi bidateye imbere.
Uburwayi n'impfu za kanseri y'inkondo y'umura ku isi byagabanutse cyane mu myaka 40 ishize, ibyo bikaba bifitanye isano no gushimangira inyigisho z'ubuzima, gukingira HPV no gusuzuma kanseri y'inkondo y'umura.
Indwara ikunze kugaragara cyane ku bagore bageze mu kigero cyo hagati (35-55y).20% by'imanza zibaho hejuru yimyaka 65 kandi ni gake cyane mu rubyiruko.
Uburyo bwo gusuzuma kanseri y'inkondo y'umura:
1. Isuzumabumenyi rya cytologiya ya curettage yinkondo y'umura.
Ubu buryo bushobora gutahura ibikomere by'inkondo y'umura na kanseri y'inkondo y'umura hakiri kare, kubera ko hari igipimo kibi cya 5% mi 10%, bityo abarwayi bagomba kwisuzumisha buri gihe.
Ikizamini cya Iyode.
Epitelium isanzwe yinkondo y'umura na vaginal squamous epithelium ikungahaye kuri glycogene kandi irashobora kwanduzwa umukara n'umuti wa iyode, mugihe isuri y'inkondo y'umura hamwe na epitelium idasanzwe (harimo hyperplasia idasanzwe, kanseri mu mwanya na kanseri itera) ntibibaho kandi ntibizanduzwa.
3. Biopsy yinkondo y'umura n'umuyoboro w'inkondo y'umura.
Niba cervical smear cytology ari urwego Ⅲ ~ Ⅳ, ariko biopsy yinkondo y'umura ni mibi, hagomba gufatwa ibice byinshi kugirango bisuzumwe.
4. ColposcopyExcellent iza kumwanya wa 1;serivisi ni iyambere;ubucuruzi buciriritse ni ubufatanye "ni filozofiya yumuryango wacu uhora yubahirizwa kandi ugakurikiranwa nisosiyete yacu ku ruganda ruhendutse rwo mu rwego rwo hejuru Cabozantinib Malate CAS 1140909-48-3 kuri Anti-Tumor, Kubera imikorere yacu ikomeye, twahoraga hafi ya imbere ya tekinoroji isukuye ibicuruzwa bishya.Twabaye umufatanyabikorwa wangiza ibidukikije ushobora kwishingikiriza.Dufate uyumunsi amakuru yinyongera!
Uruganda ruhendutseUbushinwa Cabozantinib Malate CAS 1140909-48-3 na Cabozantinib Malate CAS 1140909-48-3 Utanga isoko, ubu dufite uburambe bwimyaka 8 yumusaruro nuburambe bwimyaka 5 mubucuruzi nabakiriya kwisi yose.abakiriya bacu bakwirakwijwe cyane muri Amerika ya ruguru, Afurika n'Uburayi bw'Uburasirazuba.turashobora gutanga ibicuruzwa byiza cyane hamwe nigiciro cyapiganwa cyane.